Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,033.21 +14.82 (+0.30%) Dow
38,038.80 +135.51 (+0.36%) Nasdaq
15,709.24 +103.76 (+0.66%) Bitcoin USD
59,352.95 +2,297.86 (+4.03%) CMC Crypto 200
1,275.99 +5.25 (+0.41%)
Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:37AM EDT. Market open.
| Previous close | 0.5438 |
| Open | 0.5700 |
| Bid | 0.5206 x 600 |
| Ask | 0.5339 x 100 |
| Day's range | 0.5150 - 0.5700 |
| 52-week range | 0.2900 - 1.6700 |
| Volume | |
| Avg. volume | 2,423,940 |
| Market cap | 109.101M |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4800 |
| Earnings date | 02 May 2024 - 04 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.50 |
Business WireSangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
Simply Wall St.What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
Business WireSangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
© 2024 Yahoo. All rights reserved.